PL2132215T3 - Związki do zapobiegania lub leczenia zakażeń wirusowych i sposoby ich stosowania - Google Patents

Związki do zapobiegania lub leczenia zakażeń wirusowych i sposoby ich stosowania

Info

Publication number
PL2132215T3
PL2132215T3 PL08762936T PL08762936T PL2132215T3 PL 2132215 T3 PL2132215 T3 PL 2132215T3 PL 08762936 T PL08762936 T PL 08762936T PL 08762936 T PL08762936 T PL 08762936T PL 2132215 T3 PL2132215 T3 PL 2132215T3
Authority
PL
Poland
Prior art keywords
compounds
preventing
methods
viral infections
treating viral
Prior art date
Application number
PL08762936T
Other languages
English (en)
Inventor
Luis M Schang
Vincent Mireille R St
Alexey V Ustinov
Original Assignee
Univ Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alberta filed Critical Univ Alberta
Publication of PL2132215T3 publication Critical patent/PL2132215T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/09—Pyrimidine radicals with arabinosyl as the saccharide radical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL08762936T 2007-02-28 2008-02-27 Związki do zapobiegania lub leczenia zakażeń wirusowych i sposoby ich stosowania PL2132215T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89195407P 2007-02-28 2007-02-28
PCT/IB2008/001625 WO2008104893A2 (en) 2007-02-28 2008-02-27 Compounds for preventing or treating viral infections and methods of use thereof
EP08762936.6A EP2132215B1 (en) 2007-02-28 2008-02-27 Compounds for preventing or treating viral infections and methods of use thereof

Publications (1)

Publication Number Publication Date
PL2132215T3 true PL2132215T3 (pl) 2016-04-29

Family

ID=39721661

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08762936T PL2132215T3 (pl) 2007-02-28 2008-02-27 Związki do zapobiegania lub leczenia zakażeń wirusowych i sposoby ich stosowania

Country Status (8)

Country Link
US (1) US8633308B2 (pl)
EP (1) EP2132215B1 (pl)
JP (1) JP5539735B2 (pl)
CN (1) CN101679472B (pl)
CA (1) CA2679257C (pl)
ES (1) ES2552012T3 (pl)
PL (1) PL2132215T3 (pl)
WO (1) WO2008104893A2 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103864882B (zh) * 2012-03-31 2015-10-28 广西师范大学 齐墩果酸-嘧啶类缀合物及其制备方法和应用
CN102633855B (zh) * 2012-03-31 2014-08-20 广西师范大学 齐墩果酸-尿嘧啶核苷缀合物及其制备方法和应用
CN103467550B (zh) * 2013-09-22 2015-05-27 河南师范大学 5-环己基阿糖尿苷、制备方法及其应用
JP6308867B2 (ja) * 2014-05-23 2018-04-11 学校法人日本大学 ウラシルヌクレオシド誘導体、ウラシルヌクレオチド誘導体及びポリヌクレオチド誘導体ならびにそれらを含むプローブ
CN117379452A (zh) * 2014-06-24 2024-01-12 艾丽奥斯生物制药有限公司 取代的核苷、核苷酸和其类似物
CA3011538A1 (en) * 2016-01-18 2017-07-27 Arisan Therapeutics Adamantane derivatives for the treatment of filovirus infection
WO2019018185A1 (en) 2017-07-15 2019-01-24 Arisan Therapeutics Inc. ENANTIOMERICALLY PURE ADAMATANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTIONS

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104165D0 (en) * 1991-02-27 1991-04-17 Wellcome Found Novel entities for hiv therapy
US5658956A (en) * 1991-03-01 1997-08-19 Warner-Lambert Company Bioadhesive-wound healing compositions and methods for preparing and using same
DE69435067T2 (de) 1993-12-13 2008-05-15 Avanir Pharmaceuticals, La Jolla Formulierungen aus n-docosanol und saccharoseestern
US20030078416A1 (en) 1996-04-30 2003-04-24 Yitzhak Tor Substituted phenanthrolines
US6180615B1 (en) 1999-06-22 2001-01-30 Cv Therapeutics, Inc. Propargyl phenyl ether A2A receptor agonists
MXPA02001616A (es) * 1999-08-13 2003-10-14 Cinecast Llc Sistema y metodo para proveer y exhibir digitalmente informacion de anuncios en cinemas y cines.
GB0009486D0 (en) * 2000-04-17 2000-06-07 Univ Cardiff Chemical compounds
ATE491459T1 (de) 2000-10-18 2011-01-15 Pharmasset Inc Modifizierte nukleoside zur behandlung von virusinfektionen und abnormaler zellulärer proliferation
WO2003053360A2 (en) 2001-12-20 2003-07-03 Pharmassett Ltd. Treatment of ebv and khsv infection and associated abnormal cellular proliferation
EP1674104A1 (en) * 2004-12-24 2006-06-28 Institut National De La Sante Et De La Recherche Medicale (Inserm) Uridine derivatives as antiviral drugs against a flaviviridae, especially HCV
EP1820804A1 (en) * 2006-02-20 2007-08-22 Humboldt-Universität zu Berlin Lipidated oligonucleotides

Also Published As

Publication number Publication date
EP2132215B1 (en) 2015-09-23
WO2008104893A3 (en) 2011-04-21
JP2010520191A (ja) 2010-06-10
US20120135954A1 (en) 2012-05-31
CN101679472B (zh) 2014-07-02
EP2132215A2 (en) 2009-12-16
US8633308B2 (en) 2014-01-21
CN101679472A (zh) 2010-03-24
WO2008104893A2 (en) 2008-09-04
CA2679257C (en) 2017-04-04
CA2679257A1 (en) 2008-09-04
JP5539735B2 (ja) 2014-07-02
ES2552012T3 (es) 2015-11-25

Similar Documents

Publication Publication Date Title
GB2471806B (en) Compositions and methods for treating viral infections
LT1951272T (lt) Lactobacillus panaudojimas virusinių infekcijų gydymui
SI2079760T1 (sl) Sestavki in metode za zdravljenje okužb
IL210319A0 (en) Compounds and pharmaceutical compositions for the treatment of viral infections
IL195272A0 (en) Methods and compositions for the treatment of viral infections
IL200116A0 (en) Compounds and pharmaceutical compositions for the treatment of viral infections
IL213070A0 (en) Methods for the treatment of infections and tumors
IL209895A (en) Compounds for the prevention and / or treatment of β-amyloidoses
ZA201001391B (en) Tetracyclic indole derivatives and their use for treating or preventing viral infections
IL198087A0 (en) Methods of inactivating viruses
IL207170A0 (en) Methods of treating viral infections
GB0718446D0 (en) Compositions and methods for the treatment of infection
AP2009004840A0 (en) Compounds and methods for treatment of HCV
PL2254589T3 (pl) Związki i sposoby zapobiegania lub leczenia restenozy
PL2132215T3 (pl) Związki do zapobiegania lub leczenia zakażeń wirusowych i sposoby ich stosowania
ZA200904068B (en) Anti-tsg101 antibodies and their uses for treatment of viral infections
IL197783A0 (en) Polycyclic agents for the treatment of respiratory syncytial virus infections
ZA200802934B (en) Use of lactobacillus for treatment of virus infections
PL2117563T3 (pl) Zastosowanie antybiotyków amidynoantracyklinowych do leczenia infekcji wirusowych
GB0608792D0 (en) Method for treatment and prophylaxis of viral influenza infections
ZA201103090B (en) Herbal composition and method for the treatment of viral infection
ZA200902434B (en) Compounds and methods for treatment of HCV
IL205339A0 (en) Compounds and methods for the treatment of cancer
ZA200800201B (en) Composition and the use thereof for the treatment of viral infections
ZA200805398B (en) Use of kcnq-openers for treating or reducing the symptons of schizophrenia